This announcement is a separate document:
关于国药集团财务有限公司2024年半年度风险持续评估的报告
Report on the 2024 semi-annual risk continuity assessment of Sinopharm Group Finance Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.